BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Target therapy
1
New approaches for patients with advanced radioiodine-refractory thyroid cancer
1/22/2022 6:17:12 AM | Browse: 367 | Download: 727
2
Molecular heterogeneity in intrahepatic cholangiocarcinoma
12/18/2020 5:58:43 AM | Browse: 724 | Download: 1511
3
Advance in metabolism and target therapy in breast cancer stem cells
11/26/2020 10:14:32 AM | Browse: 650 | Download: 1531
4
Bone marrow microenvironment: The guardian of leukemia stem cells
8/26/2019 10:16:55 AM | Browse: 894 | Download: 1165
5
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
7/12/2017 6:45:23 AM | Browse: 1106 | Download: 1877
6
Changing strategies for target therapy in gastric cancer
1/15/2016 3:02:00 PM | Browse: 1012 | Download: 1705
7
Mitochondrial uncoupling protein 2 and pancreatic cancer: A new potential target therapy
12/10/2015 10:35:00 AM | Browse: 1267 | Download: 1774
8
Advanced non-small cell lung cancer in elderly patients: A review
8/4/2015 12:50:00 PM | Browse: 1170 | Download: 1909
9
Role of E3 ubiquitin ligases in gastric cancer
1/20/2015 9:10:00 PM | Browse: 1284 | Download: 1401
10
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
11/10/2014 7:09:00 PM | Browse: 1060 | Download: 1535
11
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
8/29/2014 2:41:00 PM | Browse: 1124 | Download: 1224
12
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
8/29/2014 11:31:00 AM | Browse: 939 | Download: 1235
13
Novel agents and new therapeutic approaches for treatment of multiple myeloma
8/20/2014 9:00:00 PM | Browse: 1114 | Download: 1360
14
Personalizing medicine for metastatic colorectal cancer: Current developments
8/18/2014 5:14:00 PM | Browse: 1200 | Download: 1180
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345